Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
17.50
+0.19 (1.10%)
At close: Oct 7, 2026, 4:00 PM EDT
17.69
+0.19 (1.09%)
After-hours: Oct 7, 2026, 7:30 PM EDT
Sarepta Therapeutics Market Cap
Sarepta Therapeutics has a market cap or net worth of $1.85 billion as of October 7, 2026. That makes Sarepta Therapeutics the world's 7,135th most valuable company and 1,834th in the United States. Its market cap has decreased by 18.67% in one year.
Market Cap
1.85B
Enterprise Value
2.12B
1-Year Change
-18.67%
Global Rank
Country Rank
#1,834 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Sarepta Therapeutics's market cap has increased from $58.40M to $1.85B, an increase of 3,065.19%. That is a compound annual growth rate of 13.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 1.85B | -18.03% |
| Dec 31, 2025 | 2.26B | -80.58% |
| Dec 31, 2024 | 11.61B | 28.75% |
| Dec 29, 2023 | 9.02B | -20.70% |
| Dec 30, 2022 | 11.37B | 45.06% |
| Dec 31, 2021 | 7.84B | -41.72% |
| Dec 31, 2020 | 13.45B | 39.87% |
| Dec 31, 2019 | 9.62B | 31.90% |
| Dec 31, 2018 | 7.29B | 102.79% |
| Dec 29, 2017 | 3.60B | 140.16% |
| Dec 30, 2016 | 1.50B | -14.27% |
| Dec 31, 2015 | 1.75B | 192.17% |
| Dec 31, 2014 | 597.80M | -21.92% |
| Dec 31, 2013 | 765.60M | 16.58% |
| Dec 31, 2012 | 656.70M | 549.55% |
| Dec 30, 2011 | 101.10M | -57.54% |
| Dec 31, 2010 | 238.10M | 47.70% |
| Dec 31, 2009 | 161.20M | 244.44% |
| Dec 31, 2008 | 46.80M | -38.26% |
| Dec 31, 2007 | 75.80M | -54.99% |
| Dec 29, 2006 | 168.40M | 10.50% |
| Dec 30, 2005 | 152.40M | 79.51% |
| Dec 31, 2004 | 84.90M | -33.15% |
| Dec 31, 2003 | 127.00M | -3.93% |
| Dec 31, 2002 | 132.20M | -47.73% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lakefront Biotherapeutics NV | 1.92B |
| Palvella Therapeutics | 1.91B |
| Xencor | 1.91B |
| Agios Pharmaceuticals | 1.87B |
| Zymeworks | 1.86B |
| Mesoblast | 1.84B |
| Zenas BioPharma | 1.82B |
| Intellia Therapeutics | 1.79B |